NAUT - Nautilus Biotechnolo...

Valuation of Nautilus Biotechnology, Inc.(NAUT), Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platf

Nautilus Biotechnology, Inc.

NAUT

NASDAQ

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.

2.46 USD

0.12 (4.88%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Valuation Date:

Apr 19, 2024 4:00 PM

Share Price on Valuation Date

$2.46

Stock Beta

1.003

Shares Outstanding

125098000

FMP

Home Terms of Service Privacy Policy Blog Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.